Understanding ruptured liver cancer in Assiut hospitals
Part of Cancer clinical trials.
This study looks at why some liver cancer tumors rupture (burst) and what happens afterward. If you have had a spontaneous liver tumor rupture, the researchers want to learn about your diagnosis and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a liver cancer called HCC (hepatocellular carcinoma).
- Your liver tumor has ruptured (burst) on its own, not from an injury.
- The rupture was confirmed by an imaging scan or during surgery.
- You are at least 18 years old.
- You were admitted to the hospital for this condition during the study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients with liver cancer (HCC) who had a procedure called TACE (chemoembolization) after surgery. It aims to understand why some people develop a liver abscess (a pocket of infection) after TACE and how that affects their outcome.
This study reviews medical records of people diagnosed with hepatocellular carcinoma (liver cancer) between 2015 and 2023 to better understand how the disease progresses and how different treatments work. Your information helps researchers learn what care approaches work best for future patients.
This trial is studying people with liver cancer (hepatocarcinoma) whose cancer returns (recurs) or never fully goes away (persists) after surgery. It looks at patterns after treatment at a specific study center, which may help guide better care for future patients.
This trial studies patients with liver cancer, including both the common type (hepatocellular carcinoma) and other types. It aims to understand the cancer better by collecting blood samples and medical information.
This study uses non-invasive tests, like scans or blood tests, to predict how well people with liver cancer (hepatocellular carcinoma, or HCC) will do after curative treatment. It may help doctors better understand your condition without needing invasive procedures.
This study follows people with hepatocellular carcinoma (HCC), a type of liver cancer, to learn how it changes over time. It may help improve understanding of which patients benefit from different care approaches.
Hear when a new HCC Rupture trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.